Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-02

Clinical Trial Update: The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk (FLAVASCULAR Study) [NA]

View source ↗

Summary

The FLAVASCULAR trial evaluating apple-derived flavanols for cardiovascular disease risk has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apple-derived flavanols (flavanols)

Snippet

Sponsor: Quadram Institute Bioscience | Conditions: Blood Pressure | NA | Status: COMPLETED